Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is the most common progressive neurodegenerative disease worldwide, but its cause remains unclear. Although a few drugs can provide temporary and partial relief of symptoms in some patients, no curative treatment is available. Therefore, attention has been focused on research using stem cells to treat AD. Among stem cells, mesenchymal stem cells (MSCs) have been used to treat the related pathologies in animal models of AD, and other neurodegenerative disease. This review describes latest research trends on the use of MSC-based therapies in AD and its action of mechanism. MSCs have several beneficial effects. They would be specified as the reduction of neuroinflammation, the elimination of amyloid-β, neurofibrillary tangles, and abnormal protein degradation, the promotion of autophagy-associated and blood-brain barrier recoveries, the upregulation of acetylcholine levels, improved cognition, and the recovery of mitochondrial transport. Therefore, this review describes the latest research trends in MSC-based therapy for AD by demonstrating the importance of MSC-based therapy and understanding of its mechanisms in AD and discusses the limitations and perspectives of stem cell therapy in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Salem, A. M., Ahmed, H. H., Atta, H. M., Ghazy, M. A., & Aglan, H. A. (2014) · Cell Biology International · doi:10.1002/cbin.10331 · Cited by 56 · cited 1×
“In an AD rat model with hippocampal A (cid:2) lesions, a single intravenous injection of BM-MSCs resulted in the complete elimination of A (cid:2) [38].”
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Under normal conditions, autophagy plays an important role in maintaining cellular homeostasis by breaking down unnecessary or abnormal cellular components; however, dysfunctions in autophagy are associated with cancer, inflammatory, and neurodegenerative diseases [43, 44].”
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511 · cited 1×
“Fourth, MSCs are rarely immunogenic as they do not express MHC class II or co-stimulatory molecules (CD80, CD86, or CD40) [17], as well as suppress the activations and proliferations of T and B lymphocytes [18–20], and the differentiations and maturations of dendritic cells [21, 22].”
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · cited 2×
“BBB breakdown leads to accumulation of neurotoxic materials and the activations of astrocytes and microglia and inflammatory response [49], leading to accumulation of the fibrous scraps of cells such as pericyte and endothelial cells, which make drug absorption or therapeutic delivery to the brain…”
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 1×
“Under normal conditions, autophagy plays an important role in maintaining cellular homeostasis by breaking down unnecessary or abnormal cellular components; however, dysfunctions in autophagy are associated with cancer, inflammatory, and neurodegenerative diseases [43, 44].”
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Jiang, X.-X., Zhang, Y., Liu, B., Zhang, S.-X., Wu, Y., Yu, X.-D., & Mao, N. (2005) · Blood · doi:10.1182/blood-2004-02-0586 · Cited by 1,346
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
Tau in Alzheimer Disease and Related Tauopathies
Iqbal, K., Liu, F., Gong, C.-X., & Grundke-Iqbal, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,127 · cited 1×
“When abnormally hyperphosphorylated tau has aggregated, numbers of NFTs are increased and neuronal cell death follows [9].”
Sphingosine-1-phosphate signaling and its role in disease
Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.003 · Cited by 1,039
Adult hippocampal neurogenesis and its role in Alzheimer’s disease
Mu, Y., & Gage, F. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-85 · Cited by 1,021 · cited 1×
“Alterations in neurogenesis occur during the early stage of AD and result in neuronal loss in the hippocampus and cognitive dysfunction [61].”
Amariglio, N., Hirshberg, A., Scheithauer, B. W., Cohen, Y., Loewenthal, R., Trakhtenbrot, L., Paz, N., Koren-Michowitz, M., Waldman, D., Leider-Trejo, L., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000029 · Cited by 933 · cited 1×
“For example, a patient with ataxia telangiectasia was transplanted NSCs, and he was diagnosed with multifocal brain tumor after four years [87].”
Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine
Keshtkar, S., Azarpira, N., & Ghahremani, M. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0791-7 · Cited by 907
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Blurton-Jones, M., Kitazawa, M., Martinez-Coria, H., Castello, N. A., Müller, F.-J., Loring, J. F., Yamasaki, T. R., Poon, W. W., Green, K. N., & LaFerla, F. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901402106 · Cited by 860 · cited 1×
“It was also reported intrahippocampal transplantation of NPCs improved cognitive deficits by increasing BDNF-mediated synaptic density and axonal out-growth of hippocampus in 3 × Tg AD mice [75].”
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843 · cited 1×
“When stem cells are transplanted, they secreted proteins to the surrounding environment referred as paracrineeffects[65].”
Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later
Bond, A. M., Ming, G.-L., & Song, H. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.003 · Cited by 791
Transcellular degradation of axonal mitochondria
Davis, C.-H. O., Kim, K.-Y., Bushong, E. A., Mills, E. A., Boassa, D., Shih, T., Kinebuchi, M., Phan, S., Zhou, Y., Bihlmeyer, N. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404651111 · Cited by 673
Self-citationMemory loss in Alzheimer's disease
Jahn, H. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/hjahn · Cited by 653 · cited 1×
“BrainsizeisreducedinADpatientsdueto neurondamageinthehippocampusandcortex[4].”
Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A. I., Ware, C. B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., & Murry, C. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-6769com · Cited by 646
Mesenchymal stem cells: Cell therapy and regeneration potential
Brown, C., McKee, C., Bakshi, S., Walker, K., Hakman, E., Halassy, S., Svinarich, D., Dodds, R., Govind, C. K., & Chaudhry, G. R. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2914 · Cited by 609
Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
Lukomska, B., Stanaszek, L., Zuba-Surma, E., Legosz, P., Sarzynska, S., & Drela, K. (2019) · Stem Cells International · doi:10.1155/2019/9628536 · Cited by 550
Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 404
Long, Q., Upadhya, D., Hattiangady, B., Kim, D.-K., An, S. Y., Shuai, B., Prockop, D. J., & Shetty, A. K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703920114 · Cited by 401
Alzheimer’s disease, dementia, and stem cell therapy
Duncan, T., & Valenzuela, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0567-5 · Cited by 338 · cited 1×
“For example, they differentiate into neuronal cells, osteocytes, chondrocytes, or adipocytes when stimulated with proper growth factors [13–16].”
Alzheimer's Disease and Mild Cognitive Impairment
Kelley, B. J., & Petersen, R. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.008 · Cited by 326
Derivation, Characterization, and Differentiation of Human Embryonic Stem Cells
Heins, N., Englund, M. C. O., Sjöblom, C., Dahl, U., Tonning, A., Bergh, C., Lindahl, A., Hanson, C., & Semb, H. (2004) · STEM CELLS · doi:10.1634/stemcells.22-3-367 · Cited by 316 · cited 1×
“To overcome this limitation, in most studies 10 3 –10 7 stem cells are transplanted for inhibiting teratoma formation [89, 94, 95].”
Lee, H. J., Lee, J. K., Lee, H., Carter, J. E., Chang, J. W., Oh, W., Yang, Y. S., Suh, J.-G., Lee, B.-H., Jin, H. K., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.024 · Cited by 283
Self-citationGuan, J.-L., Simon, A. K., Prescott, M., Menendez, J. A., Liu, F., Wang, F., Wang, C., Wolvetang, E., Vazquez-Martin, A., & Zhang, J. (2013) · Autophagy · doi:10.4161/auto.24132 · Cited by 281
Immunomodulatory properties and therapeutic application of mesenchymal stem cells
Shi, M., Liu, Z.-W., & Wang, F.-S. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04327.x · Cited by 281 · cited 1×
“Fourth, MSCs are rarely immunogenic as they do not express MHC class II or co-stimulatory molecules (CD80, CD86, or CD40) [17], as well as suppress the activations and proliferations of T and B lymphocytes [18–20], and the differentiations and maturations of dendritic cells [21, 22].”
Czubowicz, K., Jęśko, H., Wencel, P., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 281 · cited 1×
“It is associated with dysfunctional protein clearance, impaired lyso-some production and inflammatory control functions, and A (cid:2) production as well as autophagy functions [52–54].”
Shin, J. Y., Park, H. J., Kim, H. N., Oh, S. H., Bae, J.-S., Ha, H.-J., & Lee, P. H. (2014) · Autophagy · doi:10.4161/auto.26508 · Cited by 243 · cited 2×
“Shin et al. observed intravenous administration of MSCs improved lysosome-autophagy and removed A (cid:2) by activating autophagy-associated LC3-II and BECN1/Beclin 1 [40].”
Babenko, V., Silachev, D., Popkov, V., Zorova, L., Pevzner, I., Plotnikov, E., Sukhikh, G., & Zorov, D. (2018) · Molecules · doi:10.3390/molecules23030687 · Cited by 242
Stonesifer, C., Corey, S., Ghanekar, S., Diamandis, Z., Acosta, S. A., & Borlongan, C. V. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.004 · Cited by 241
Redondo-Castro, E., Cunningham, C., Miller, J., Martuscelli, L., Aoulad-Ali, S., Rothwell, N. J., Kielty, C. M., Allan, S. M., & Pinteaux, E. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0531-4 · Cited by 239
Ochalek, A., Mihalik, B., Avci, H. X., Chandrasekaran, A., Téglási, A., Bock, I., Giudice, M. L., Táncos, Z., Molnár, K., László, L., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0317-z · Cited by 225
Current progress in the derivation and therapeutic application of neural stem cells
Tang, Y., Yu, P., & Cheng, L. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.504 · Cited by 211
Gangadaran, P., Rajendran, R. L., Lee, H. W., Kalimuthu, S., Hong, C. M., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.022 · Cited by 210 · cited 1×
“In another study, MSC-derived EVs enhanced ischemic tissue recovery and angiogenesis by activating the receptors of the angiogenic genes VEGFR1 and VEGFR2 [70].”
Self-citationExtracellular Vesicles: Multimodal Envoys in Neural Maintenance and Repair
Holm, M. M., Kaiser, J., & Schwab, M. E. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.006 · Cited by 209 · cited 1×
“EVs can be transferred to target cells through the BBB without being degraded in blood because they are surrounded by a lipid bilayer [69].”
Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
Wang, Y.-J., Zhou, H.-D., & Zhou, X.-F. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.004 · Cited by 205 · cited 1×
“However, defective clearance of A (cid:2) causes its accumulation and damage to synapses and neurons in the hippocampus and cortex under abnormal conditions, and eventually progresses into AD [7].”
Schmidt, N. O., Przylecki, W., Yang, W., Ziu, M., Teng, Y. D., Kim, S. U., Black, P. M., Aboody, K. S., & Carroll, R. S. (2005) · Neoplasia · doi:10.1593/neo.04781 · Cited by 199
Apostolova, L. G. (2016) · Continuum · doi:10.1212/con.0000000000000307 · Cited by 198
Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells
Liu, X., Li, F., Stubblefield, E. A., Blanchard, B., Richards, T. L., Larson, G. A., He, Y., Huang, Q., Tan, A.-C., Zhang, D., et al. (2012) · Cell Research · doi:10.1038/cr.2011.181 · Cited by 191
Kim, J.-Y., Kim, D. H., Kim, J. H., Lee, D., Jeon, H. B., Kwon, S.-J., Kim, S. M., Yoo, Y. J., Lee, E. H., Choi, S. J., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.140 · Cited by 190
Self-citationLee, J. K., Jin, H. K., & Bae, J.-S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.059 · Cited by 189 · cited 1×
“In a mouse model of acute AD, bilateral hippocampus injections of BM-MSCs removed A (cid:2) by activating microglia [39].”
Self-citationBACE1 activity is modulated by cell-associated sphingosine-1-phosphate
Takasugi, N., Sasaki, T., Suzuki, K., Osawa, S., Isshiki, H., Hori, Y., Shimada, N., Higo, T., Yokoshima, S., Fukuyama, T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6467-10.2011 · Cited by 181 · cited 1×
“It is associated with dysfunctional protein clearance, impaired lyso-some production and inflammatory control functions, and A (cid:2) production as well as autophagy functions [52–54].”
Autophagy is required for self-renewal and differentiation of adult human stem cells
Salemi, S., Yousefi, S., Constantinescu, M. A., Fey, M. F., & Simon, H.-U. (2012) · Cell Research · doi:10.1038/cr.2011.200 · Cited by 175
Human neural stem cells alleviate Alzheimer-like pathology in a mouse model
Lee, I.-S., Jung, K., Kim, I.-S., Lee, H., Kim, M., Yun, S., Hwang, K., Shin, J. E., & Park, K. I. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0035-6 · Cited by 167 · cited 2×
“Transplantationofhuman NSCsintolateralventriclesinamousemodelof ADresultedindecreasedhyperphosphorylationof tauandsuppressedmicrogliosisandastrogliosisvia aTrk-dependentAkt/GSK3 (cid:2) signaling [77].”
Garcia, K. O., Ornellas, F. L. M., Martin, P. K. M., Patti, C. L., Mello, L. E., Frussa-Filho, R., Han, S. W., & Longo, B. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00030 · Cited by 167
Yang, H., Xie, Z. H., Wei, L. F., Yang, H. N., Yang, S. N., Zhu, Z. Y., Wang, P., Zhao, C. P., & Bi, J. Z. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt227 · Cited by 164
Boukelmoune, N., Chiu, G. S., Kavelaars, A., & Heijnen, C. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0644-8 · Cited by 154 · cited 1×
“Another study reported loss of DCX + neural progenitor cells in the hippocampal dentate gyrus and subventricular zone are relieved by MSC intranasal administration [60].”
Rizor, A., Pajarillo, E., Johnson, J., Aschner, M., & Lee, E. (2019) · Antioxidants · doi:10.3390/antiox8080265 · Cited by 153
Oh, S. H., Kim, H. N., Park, H.-J., Shin, J. Y., & Lee, P. H. (2015) · Cell Transplantation · doi:10.3727/096368914x679237 · Cited by 152
Basal Autophagy Decreased During the Differentiation of Human Adult Mesenchymal Stem Cells
Oliver, L., Hue, E. S., Priault, M., & Vallette, F. M. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0124 · Cited by 151 · cited 1×
“Furthermore, the activation of autophagy via Bcl-xL is known to promote MSC survival and differentiation [47].”
Moghadam, F. H., Alaie, H., Karbalaie, K., Tanhaei, S., Nasr‐Esfahani, M. H., & Baharvand, H. (2009) · Differentiation · doi:10.1016/j.diff.2009.06.005 · Cited by 149
Growth of Teratomas Derived from Human Pluripotent Stem Cells Is Influenced by the Graft Site
Cooke, M. J., Stojković, M., & Przyborski, S. A. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.254 · Cited by 124
Zhang, Q., Wu, H., Wang, Y., Gu, G., Zhang, W., & Xia, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13413 · Cited by 123
Kim, D. H., Lee, D., Chang, E. H., Kim, J. H., Hwang, J. W., Kim, J.-Y., Kyung, J. W., Kim, S. H., Oh, J. S., Shim, S. M., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0487 · Cited by 123
Self-citationEckert, A., Huang, L., Gonzalez, R., Kim, H.-S., Hamblin, M. H., & Lee, J.-P. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0184 · Cited by 121
Self-citationEfficient Differentiation of Bone Marrow Mesenchymal Stem Cells into Endothelial Cells in Vitro
Wang, C., Li, Y., Yang, M., Zou, Y., Liu, H., Liang, Z., Yin, Y., Niu, G., Yan, Z., & Zhang, B. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.10.012 · Cited by 119
Naaldijk, Y., Jäger, C., Fabian, C., Leovsky, C., Blüher, A., Rudolph, L., Hinze, A., & Stolzing, A. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12319 · Cited by 116 · cited 2×
“When BM-MSCs were transplanted into an APP/PS1 mouse model of AD via tail vein, microglial numbers in cortex, microglia sizes, and pro-inflammatory factor levels (TNF-(cid:4) and IL-6) were reduced [29].”
Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-β Secretion
Noh, M. Y., Lim, S. M., Oh, K.-W., Cho, K.-A., Park, J., Kim, K.-S., Lee, S.-J., Kwon, M.-S., & Kim, S. H. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0217 · Cited by 110 · cited 1×
“In addition, TGF-(cid:2) secreted by MSCs blocked the nuclear factor-κ B pathway and restored the TGF-(cid:2) pathway [31].”
Self-citationProtein Homeostasis, Aging and Alzheimer’s Disease
Morawe, T., Hiebel, C., Kern, A., & Behl, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8246-0 · Cited by 107 · cited 1×
“…were markedly improved [78]. iPSCs therapy iPSCs are pluripotent stem cells reprogrammed from somatic cells with four transcription factors (Oct4, Sox2, Klf4, and c-Myc) [79–81]. iPSCs can be used as disease modeling or cell source for transplantation after differentiation into neurons [82].”
Park, D., Yang, Y., Bae, D. K., Lee, S. H., Yang, G., Kyung, J., Kim, D., Choi, E., Lee, S. W., Kim, G., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.026 · Cited by 107
Self-citationPark, D., Yang, G., Bae, D. K., Lee, S. H., Yang, Y., Kyung, J., Kim, D., Choi, E., Choi, K., Kim, S. U., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23182 · Cited by 97 · cited 1×
“…levels, and cholinergic nervous system marker expressions were upregulated, and cognitive function and physical activities were markedly improved [78]. iPSCs therapy iPSCs are pluripotent stem cells reprogrammed from somatic cells with four transcription factors (Oct4, Sox2, Klf4, and c-Myc)…”
Self-citationOrganized Development from Human Embryonic Stem Cells after Injection into Immunodeficient Mice
Gertow, K., Wolbank, S., Rozell, B., Sugars, R. V., Andäng, M., Parish, C. L., Lmreh, M. P., Wendel, M., & Ährlund‐Richter, L. (2004) · Stem Cells and Development · doi:10.1089/scd.2004.13.421 · Cited by 94
Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges
Najar, M., Bouhtit, F., Melki, R., Afif, H., Hamal, A., Fahmi, H., Merimi, M., & Lagneaux, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050626 · Cited by 91
Liew, L. C., Katsuda, T., Gailhouste, L., Nakagama, H., & Ochiya, T. (2017) · International Immunology · doi:10.1093/intimm/dxx002 · Cited by 89 · cited 1×
“For example, they differentiate into neuronal cells, osteocytes, chondrocytes, or adipocytes when stimulated with proper growth factors [13–16].”
Fujiwara, N., Shimizu, J., Takai, K., Arimitsu, N. N., Saito, A., Kono, T., Umehara, T., Ueda, Y., Wakisaka, S., Tomoko, S., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.043 · Cited by 88
Prakash, A., Medhi, B., & Chopra, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.015 · Cited by 86
Zhao, Y., Chen, X., Wu, Y., Wang, Y., Li, Y., & Xiang, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00140 · Cited by 83
Plaia, T. W., Josephson, R., Liu, Y., Zeng, X., Ording, C., Toumadje, A., Brimble, S. N., Sherrer, E. S., Uhl, E. W., Freed, W. J., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0315 · Cited by 80
Žilka, N., Žilková, M., Kazmerova, Z., Šarišský, M., Cigánková, V., & Novák, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.088 · Cited by 76 · cited 2×
“The authors suggested that the cytotoxic effect of modified tau in AD can be reduced by MSCs [42].”
Kim, D. H., Lim, H., Lee, D., Choi, S. J., Oh, W., Yang, Y. S., Oh, J. S., Hwang, H. H., & Jeon, H. B. (2018) · Scientific Reports · doi:10.1038/s41598-017-18542-0 · Cited by 75
Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders
Reddy, A. P., Ravichandran, J., & Carkaci-Salli, N. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.020 · Cited by 72 · cited 1×
“Although many clinical trials of stem cell therapy have been conducted based on animal studies of stem cell transplantation, positive clinical results are not always promised [96].”
Clonal Analysis of Human Embryonic Stem Cell Differentiation into Teratomas
Blum, B., & Benvenisty, N. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0073 · Cited by 70 · cited 1×
“Teratomas have been produced by stem cell transplantation into testis [89], kidney [90], liver [91], and hind leg muscle [92].”
Hu, W., Feng, Z., Xu, J., Jiang, Z., & Feng, M. (2018) · Brain Research · doi:10.1016/j.brainres.2018.12.034 · Cited by 67
Xie, Z., Liu, Z., Zhang, X., Yang, H., Wei, L., Wang, Y., Xu, S., Sun, L., Lai, C., Bi, J., et al. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0375-0 · Cited by 65
Iwashita, M., Ohta, H., Fujisawa, T., Cho, M., Ikeya, M., Kidoaki, S., & Kosodo, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-38395-5 · Cited by 60 · cited 1×
“They established dorsal cortical neurons derived from iPSCs using high intensity (1500 Pa) collagen gel, indicating the possibility to regulate the differentiation of stem cells into specific types of neurons [97].”
Lee, H., Lee, J. K., Min, W.-K., Bae, J.-H., He, X., Schuchman, E. H., Bae, J.-S., & Jin, H. K. (2010) · Stem Cells · doi:10.1002/stem.401 · Cited by 57
Self-citationCurrent Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease
Kwak, K.-A., Lee, S., Yang, J.-Y., & Park, Y. (2018) · Stem Cells International · doi:10.1155/2018/6392986 · Cited by 54
Self-citationEffects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease
Zhang, W., Wang, G. M., Wang, P. J., Zhang, Q., & Sha, S. H. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23299 · Cited by 53
Lee, N. K., Park, S. E., Kwon, S. J., Shim, S., Byeon, Y., Kim, J., Na, D. L., & Chang, J. W. (2017) · Scientific Reports · doi:10.1038/srep39340 · Cited by 42 · cited 4×
“Stem cell transplantation has shown to reduce A (cid:2) plaque levels by reducing microglia numbers, activating proteasomes, and enhancing autophagy and (cid:2) -amyloidase secretion [33–41].”
InfluentialSelf-citationWang, F., Zhang, C., Hou, S., & Geng, X. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly221 · Cited by 39
Marfia, G., Navone, S. E., Hadi, L. A., Paroni, M., Berno, V., Beretta, M., Gualtierotti, R., Ingegnoli, F., Levi, V., Miozzo, M., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0268 · Cited by 36
Yan, Y., Bejoy, J., Marzano, M., & Li, Y. (2019) · Cells · doi:10.3390/cells8030242 · Cited by 22 · cited 1×
“…were markedly improved [78]. iPSCs therapy iPSCs are pluripotent stem cells reprogrammed from somatic cells with four transcription factors (Oct4, Sox2, Klf4, and c-Myc) [79–81]. iPSCs can be used as disease modeling or cell source for transplantation after differentiation into neurons [82].”
Kim, C., Park, J.-M., Kong, T., Lee, S.-M., Seo, K.-W., Choi, Y., Song, Y. S., & Moon, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0683-3 · Cited by 19
Self-citationCho, J. S., Lee, J., Jeong, D. U., Kim, H. W., Chang, W. S., Moon, J., & Chang, J. W. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.3.406 · Cited by 18
Self-citationCai, Y., Dai, X., Zhang, Q., & Dai, Z. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0263-7 · Cited by 18
Li, M., Inaba, M., Guo, K., Abraham, N. G., & Ikehara, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.001 · Cited by 16 · cited 2×
“The levels of inflammatory factors (IL-1 (cid:2) , IL-6, iNOS, and HO-1) were reduced, and the level of TGF-(cid:2) (a therapeutic factor) was increased, which improved inflammatory status, decreased oxidative stress, and improved cognitive function [23].”
Cell Therapy Products in Alzheimer Disease
Song, H. J., Kim, T., Lee, H., Kim, J. M., Park, Y. J., Lee, A., Kim, S. A., & Choi, H. J. (2017) · Journal of Menopausal Medicine · doi:10.6118/jmm.2017.23.1.1 · Cited by 13
Self-citationSohre, S., & Moosmann, B. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/418566 · Cited by 4
Research works printed but not linked: 1
- Alzheimer’s Disease International, 2019, World Alzheimer Report 2019. Attitudes to dementia.
Cited by
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
“Nonetheless, a small number of preclinical investigations have demonstrated advancements in the modelling of AD pathology utilizing ESCs (Kim et al., 2020a).”
BackgroundInfluentialSafiri, S., Ghaffari Jolfayi, A., Fazlollahi, A., Morsali, S., Sarkesh, A., Daei Sorkhabi, A., Golabi, B., Aletaha, R., Motlagh Asghari, K., Hamidi, S., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1474043 · Cited by 200
Sha, S., Shen, X., Cao, Y., & Qu, L. (2021) · Aging · doi:10.18632/aging.203088 · Cited by 107
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Zhang, F., Zhong, R.-J., Cheng, C., Li, S., & Le, W.-D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00565-5 · Cited by 105
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813900 · Cited by 94
“Second, they are less prone to transformation into neoplastic cells [169].”
Background
Metadata
- Authors
- Kim, J., Lee, Y., Lee, S., Kim, K., Song, M., & Lee, J.
- Affiliations
- Department of Pharmacy, College of Pharmacy, Pusan National University, Busan, Republic of Korea
- Korea Brain Research Institute (KR)
- Pusan National University (KR)
- University of Cambridge (GB)
- Corresponding author
- Song, Minjung
- Lee, Jaewon
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2020-09-01
- Volume
- 77
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W3046677722
- Cited by
- 73
- References
- 96
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 20 · 2023: 24 · 2022: 8 · 2021: 9 · 2020: 1
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- mesenchymal stem cells, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Forecasting, Humans, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.